e-learning
resources
Vienna 2003
Monday 29.09.2003
Immunology of interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytotoxic lymphocytes in different interstitial lung diseases
D. S. Papakosta, G. Kyriazis, T. N. Kontakiotis, D. Gioulekas, T. Polyzoni, D. Patakas (Exochi,Thessaloniki, Greece)
Source:
Annual Congress 2003 - Immunology of interstitial lung diseases
Session:
Immunology of interstitial lung diseases
Session type:
Poster Discussion
Number:
1514
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. S. Papakosta, G. Kyriazis, T. N. Kontakiotis, D. Gioulekas, T. Polyzoni, D. Patakas (Exochi,Thessaloniki, Greece). Cytotoxic lymphocytes in different interstitial lung diseases. Eur Respir J 2003; 22: Suppl. 45, 1514
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Angiogenic T cells in interstitial lung diseases
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021
Distribution of peripheral blood cytotoxic T lymphocytes in different histological types of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 308s
Year: 2005
Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Chosen lymphocytic subpopulations in the course of interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001
a
E
b7
integrin (CD103-
b7
) expression in bronchoalveolar T lymphocytes in interstitial lung diseases
Source: Eur Respir J 2007; 30: Suppl. 51, 576s
Year: 2007
Natural killer and natural killer T-like cells in bronchoalveolar lavage fluid and peripheral blood in diffuse lung diseases
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Subpopulation analysis of peripheral blood lymphocytes in different variants of exogenic allergic alveolitis (EAA)
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017
Cytotoxic T-lymphocyte status in peripheral blood and malignant pleural effusion in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 63s
Year: 2003
Exhausted T lymphocytes in chronic obstructive pulmonary disease: single-cell analysis of human lung tissue
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients
Source: Eur Respir J 2008; 31: 1167-1176
Year: 2008
Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Invariant natural killer Tcells (iNKT) in BAL fluid in diffuse parenchymal lung diseases: Preliminary results
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
B-cell infiltration varies among patients with interstitial lung diseases
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis
Source: Eur Respir J 2007; 30: 165-171
Year: 2007
Expression phenotypes of CD4+ and CD8+ T lymphocytes in bronchoalveolar lavage fluid and blood in lung fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD)
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Different profiles of lung and systemic regulatory T cells in mild asthmatics
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept